EFFORTLESS Trial Of Boston Scientific’s S-ICD Headlines HRS 2016
Executive Summary
Results from EFFORTLESS, the largest post-market registry of Boston Scientific’s S-ICD (subcutaneous ICD), support the technology as an option for a broad population of ICD candidates. Researchers presented data from the registry on May 6 at the Heart Rhythm Society Scientific Sessions in San Francisco.